Levofloxacin for Typhoid Acquired in Ghana (100 kg, normal renal function)
Use levofloxacin 750 mg orally once daily for 7 days; do not extend beyond 10 days if the patient is clinically responding. 1, 2, 3
- Rationale and hierarchy of evidence (mortality/morbidity/QOL focus):
- FDA label establishes adult dosing bands and safety profile; 750 mg q24h is an approved high-exposure regimen for serious Gram-negative infections in adults with CrCl ≥50 mL/min, with typical treatment durations 3–14 days; no renal adjustment is needed here 1.
- Clinical studies in uncomplicated enteric fever demonstrate high cure rates with levofloxacin 500–750 mg daily for 7 days, supporting a short-course high-dose regimen that minimizes relapse risk and adverse events burden, thus improving QOL while avoiding prolonged fluoroquinolone toxicity 2, 3.
- Although some PK/PD research suggests higher doses for high MIC pathogens, this is not needed in a clinically responding, culture-susceptible case; higher doses (≥1000–1500 mg) carry greater toxicity without proven outcome benefits in real-world typhoid care 4, 5, 6.
Stepwise algorithm
- If adult, CrCl ≥50 mL/min, clinically responding typhoid:
- If any renal impairment (CrCl <50 mL/min): adjust per FDA renal dosing table (not applicable here) 1.
- If intolerance/toxicity or evidence of fluoroquinolone resistance emerges despite initial response: switch to a non-fluoroquinolone active agent per local susceptibility (e.g., azithromycin or ceftriaxone), favoring options with strong activity in contemporary Salmonella Typhi resistance patterns to protect morbidity/mortality/QOL.
Practical administration and safety (to reduce harms)
- Separate from antacids/iron/zinc/sucralfate by ≥2 hours to avoid chelation and treatment failure 1.
- Maintain hydration; monitor for C. difficile diarrhea, tendinopathy, QT prolongation, CNS effects, dysglycemia; stop drug if serious AEs occur 1.
- No weight-based adjustment is needed at 100 kg with normal renal function for levofloxacin; 750 mg achieves high exposure while limiting toxicity versus experimental higher doses 1, 4.
Common pitfalls to avoid
- Prolonging therapy beyond 10 days without complications increases adverse events without proven benefit 1.
- Co-administering with metal cations (antacids, iron, zinc) leading to underexposure and relapse 1.
- Empirically escalating to ≥1000 mg daily in a responding patient—higher doses lack outcome benefit and raise toxicity risk in routine typhoid care 4, 5, 6.